Published TCIMAIL newest issue No.197 | New tool "TCI SpectraViewer" | [TCIPracticalExample] The Synthesis of Rubicene... | Product Document Searching Made Easy by 2D Code!
Maximum quantity allowed is 999
CAS RN: 189224-26-8 | Product Number: O0660
Ozagrel Sodium

Purity: >98.0%(T)(HPLC)
- Sodium Ozagrel
- Sodium (E)-3-[4-[(1H-Imidazol-1-yl)methyl]phenyl]acrylate
- Sodium (2E)-3-[4-(1H-Imidazol-1-ylmethyl)phenyl]acrylate
Size | Unit Price | Hyderabad | Japan* | Quantity |
---|---|---|---|---|
1G |
₹2,400.00
|
Contact Us | 31 |
|
5G |
₹7,500.00
|
Contact Us | 26 |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | O0660 |
Purity / Analysis Method | >98.0%(T)(HPLC) |
Molecular Formula / Molecular Weight | C__1__3H__1__1N__2NaO__2 = 250.23 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
Store Under Inert Gas | Store under inert gas |
Condition to Avoid | Air Sensitive |
CAS RN | 189224-26-8 |
MDL Number | MFCD00875845 |
Appearance | White to Light yellow powder to crystal |
Purity(HPLC) | min. 95.0 area% |
Purity(Nonaqueous Titration) | min. 98.0 % |
NMR | confirm to structure |
Solubility (soluble in) | Methanol |
Solubility (insoluble in) | Ethanol |
Pictogram |
![]() |
Signal Word | Warning |
Hazard Statements | H371 : May cause damage to organs. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P260 : Do not breathe dust. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P308 + P311 : IF exposed or concerned: Call a POISON CENTER/doctor. P405 : Store locked up. |
References
- Pharmacological studies on the TXA synthetase inhibitor (E)-3-[p-(1H-imidazol-1-ylmethyl)phenyl]-2-propenoic acid (OKY-046)
- Effects of thromboxane synthetase inhibitors on aggregation of rabbit platelets
- Thromboxane A2 inhibition: Therapeutic potential in bronchial asthma (a review)
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.